Healthcare news

Featured image of the article Hansoh Pharma and Roche forge global alliance to advance CDH17-targeting ADCs for solid tumors.

Hansoh Pharma and Roche forge global alliance to advance CDH17-targeting ADCs for solid tumors

Posted on by

SOPHIA ANTIPOLIS, France – October 24, 2025 │ Hansoh Pharmaceutical has signed a license agreement with Roche to develop HS-20110, a CDH17-targeting antibody-drug conjugate (ADC) utilizing a clinically validated topoisomerase inhibitor payload. Hansoh Pharma gives Roche an exclusive worldwide license (excluding the Chinese Mainland, Hong Kong, Macau and Taiwan) to advance the clinical development and[…]

Featured image of the article Next-Generation mRNA Innovators: Pioneering RNA Delivery and Methane-Targeting Vaccines

Next-Generation mRNA Innovators: Pioneering RNA Delivery and Methane-Targeting Vaccines

Posted on by

SOPHIA ANTIPOLIS, France – October 17, 2025 │ This quarter, KnowMade’s Therapeutic mRNA patent monitoring service reveals two emerging players shaping the next wave of RNA innovation: Parcel Bio, pioneering nanoparticle-free delivery, and ArkeaBio, developing mRNA vaccines for methane mitigation. Two Emerging Players Expand the Frontiers of Therapeutic mRNA Innovation Two new entrants have emerged[…]

Featured image of the article CILA Therapeutics: A Newcomer Shaping Pulmonary Drug and mRNA Delivery.

CILA Therapeutics: A Newcomer Shaping Pulmonary Drug and mRNA Delivery

Posted on by

SOPHIA ANTIPOLIS, France – July 16, 2025 │ KnowMade actively tracks therapeutic mRNA innovations as part of its Therapeutic mRNA patent monitoring service. What’s new today? Spotlight on Emerging Innovators: The Strategic Value of Patent Monitoring The first half of 2025 confirms the ongoing momentum in therapeutic mRNA innovation, as highlighted in KnowMade’s press release[…]

Featured image of the article Amplitude Therapeutics a promising newcomer in therapeutic mRNA field.

Amplitude Therapeutics a promising newcomer in therapeutic mRNA field

Posted on by

SOPHIA ANTIPOLIS, France – July 11, 2025 │ KnowMade actively tracks therapeutic mRNA innovations as part of its Therapeutic mRNA patent monitoring service. What’s new today? Emerging Innovators in a Record-Setting Quarter for Therapeutic mRNA The continued innovation in therapeutic mRNA is confirmed through the first half of 2025, as reflected by KnowMade’s Therapeutic mRNA[…]